Fig. 2From: No preclinical rationale for IGF1R directed therapy in chondrosarcoma of boneRelative cell viability of 72 hours of treatment with IGF1R/IR inhibitors. a-b OSI-906 does not inhibit chondrosarcoma cell viability, even in the presence of IGF1. c-d IGF1R inhibitors NVP-ADW742 and GSK1838705A do not inhibit chondrosarcoma cell viabilityBack to article page